Inspire Investing, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Inspire Investing, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$307,170
-66.6%
3,429
-68.3%
0.04%
-64.9%
Q2 2023$920,023
+239.6%
10,806
+230.1%
0.11%
+226.5%
Q1 2023$270,924
+14.6%
3,274
+8.9%
0.03%
+13.3%
Q4 2022$236,501
+14.3%
3,007
+7.6%
0.03%
+3.4%
Q3 2022$207,000
-1.4%
2,795
-13.1%
0.03%
+3.6%
Q2 2022$210,000
-11.4%
3,218
-14.2%
0.03%
+3.7%
Q1 2022$237,000
-1.7%
3,751
-17.5%
0.03%
-3.6%
Q4 2021$241,000
+1.3%
4,544
+35.0%
0.03%
-6.7%
Q3 2021$238,000
+317.5%
3,366
+242.1%
0.03%
-37.5%
Q4 2017$57,0009840.05%
Other shareholders
HAEMONETICS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders